EPIDEMIOLOGICAL CHARACTERISTICS OF PNEUMOCOCCAL MENINGITIS IN THE RUSSIAN FEDERATION IN 2011
- Authors: BELOSHITSKY G.V.1, KOROLEVA I.S1
-
Affiliations:
- Issue: No 2 (2013)
- Pages: 32-35
- Section: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/276544
- ID: 276544
Cite item
Open Access
Access granted
Abstract
Central Research Institute of Epidemiology, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare, Moscow The paper analyzes the epidemic situation associated with the incidence of pneumococcal meningitis in the Russian Federation, compares the basic epidemiological parameters in 2010 and 2011, and estimates the status of laboratory diagnosis of pneumococcal meningitis in the regions of the Russian Federation.
Full Text
References
- Информационно-аналитические обзори «Менингококковая инфекция и гнойние бактериальние менингиты в Российской Федерации». 2002—2010 гг. М.: Российский Центр по эпидемиологическому надзору за МИ и ГБМ, 2002—2010.
- Bingen E., Levy C., Varon E. et al. Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation. Eur. J. Clin. Microbiol. Infect. Dis. 2008; 27: 191—199.
- Laboratory Centre for Disease Control, Health Canada, Notifiable diseases annual summary 1994. Canada Immun. Dis. Rep. 1997; 23(Suppl 9): 28—30.
- Dery M., Hasbun R. Changing epidemiology of bacterial meningitis. Curr. Infect. Dis. Rep. 2007; 9: 301—307.
- Sigurdardottir B., Bjornsson O.M. et al. Acute bacterial meningitis in adults. A 20-year overview. Arch. Intern. Med. 1997; 157: 425—429.
- Schuchat A., Robinson K., Wenger J.D., Harrison L.H., Farley M., Reingold A.L. et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N. Engl. J. Med. 1997; 337: 970—976.
- McIntosh E.D.G., Fritzell B., Fletcher M.A. Burden of paediatric invasive pneumococcal disease in Europe, 2005. Epidemiology and Infection. 2007; 135(4): 644 — 656.
- Hausdorff W.P., Bryant J., Paradiso P.R., Siber G.R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin. Infect. Dis. 2000; 30(1): 100—121.
- Письмо Роспотребнадзора № 01/9620-0-32 от 29.06.2010 «О взаимодействии территориальних органов и учреждений Роспотребнадзора с Референс-центром по мониторингу за бактериальными менингитамы».
Supplementary files
